Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 57 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Keyword is C-Reactive Protein  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., & Liapis C. D. (2010).  Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.. J Vasc Surg. 51(1), 114-21.
Saratzis, A., Melas N., Hunter J. P., Dixon H., Nightingale P., Kiskinis D., et al. (2012).  Anemia is associated with mortality following endovascular repair of abdominal aortic aneurysm.. Vasc Endovascular Surg. 46(3), 223-8.
Deftereos, S., Giannopoulos G., Angelidis C., Alexopoulos N., Filippatos G., Papoutsidakis N., et al. (2015).  Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.. Circulation. 132(15), 1395-403.
Eraly, S. A., Nievergelt C. M., Maihofer A. X., Barkauskas D. A., Biswas N., Agorastos A., et al. (2014).  Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.. JAMA Psychiatry. 71(4), 423-31.
B
Kadoglou, N. P. E., Gerasimidis T., Kapelouzou A., Moumtzouoglou A., Avgerinos E. D., Kakisis J. D., et al. (2010).  Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.. Eur J Vasc Endovasc Surg. 39(3), 258-65.
C
Eleftheriadis, T., Antoniadi G., Liakopoulos V., & Stefanidis I. (2013).  Can a single inflammatory marker adequately predict resistance to erythropoiesis-stimulating agents in hemodialysis patients?. Hemodial Int. 17(1), 130-1.
Ziakas, A., Gavrilidis S., Souliou E., Giannoglou G., Stiliadis I., Karvounis H., et al. (2009).  Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.. Angiology. 60(1), 50-9.
Savvidou, S., Karatzidou K., Tsakiri K., Gagalis A., Hytiroglou P., & Goulis J. (2016).  Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide.. Diabetes Res Clin Pract. 113, 125-34.
Sakellariou, G. T., Anastasilakis A. D., Bisbinas I., Oikonomou D., Gerou S., Polyzos S. A., et al. (2015).  Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.. Rheumatology (Oxford). 54(5), 908-14.
Chatzimavroudis, G., Pavlidis T. E., Koutelidakis I., Giamarrelos-Bourboulis E. J., Atmatzidis S., Kontopoulou K., et al. (2009).  CO(2) pneumoperitoneum prolongs survival in an animal model of peritonitis compared to laparotomy.. J Surg Res. 152(1), 69-75.
Agapakis, D. I., Tsantilas D., Psarris P., Massa E. V., Kotsaftis P., Tziomalos K., et al. (2010).  Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia.. Respirology. 15(5), 796-803.
Souglis, A., Bogdanis G. C., Giannopoulou I., Papadopoulos C., & Apostolidis N. (2015).  Comparison of inflammatory responses and muscle damage indices following a soccer, basketball, volleyball and handball game at an elite competitive level.. Res Sports Med. 23(1), 59-72.
Artemiou, P., Charokopos N., Rouska E., Sabol F., Chrysogonidis I., Tsavdaridou V., et al. (2012).  C-reactive protein/interleukin-6 ratio as marker of the size of the uncomplicated thoracic aortic aneurysms.. Interact Cardiovasc Thorac Surg. 15(5), 871-7.
Sandoo, A., Dimitroulas T., Hodson J., Smith J. P., Douglas K. M., & Kitas G. D. (2015).  Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study.. Rheumatology (Oxford). 54(7), 1145-52.
D
Eleftheriadis, T., Kartsios C., Yiannaki E., Antoniadi G., Kazila P., Pliakos K., et al. (2009).  Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.. Nephrology (Carlton). 14(5), 471-5.
Athyros, V. G., Kakafika A. I., Karagiannis A., & Mikhailidis D. P. (2008).  Do we need to consider inflammatory markers when we treat atherosclerotic disease?. Atherosclerosis. 200(1), 1-12.
E
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Tziomalos K., Peletidou A., Vosikis C., et al. (2011).  Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors.. Nutr Metab Cardiovasc Dis. 21(3), 213-21.
Sambanis, C., Tziomalos K., Kountana E., Kakavas N., Zografou I., Balaska A., et al. (2008).  Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.. Acta Diabetol. 45(1), 23-30.
Zografou, I., Sampanis C., Gkaliagkousi E., Iliadis F., Papageorgiou A., Doukelis P., et al. (2015).  Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.. Hormones (Athens). 14(1), 118-25.
Lazich, I., Sarafidis P., de Guzman E., Patel A., Oliva R., & Bakris G. (2012).  Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.. Diabetes Obes Metab. 14(2), 181-6.
Kirmizis, D., Papagianni A., Dogrammatzi F., Skoura L., Belechri A-M., Alexopoulos E., et al. (2010).  Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.. J Atheroscler Thromb. 17(12), 1256-65.
Kirmizis, D., Papagianni A., Dogrammatzi F., Belechri A-M., Alexopoulos E., Efstratiadis G., et al. (2012).  The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.. Ren Fail. 34(9), 1135-9.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.. Int Angiol. 30(3), 295; author reply 296.
Kostakou, P., Kolovou G., Anagnostopoulou K., Theodoridis T., Galea V., Mihas C., et al. (2010).  Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia.. Arch Cardiovasc Dis. 103(1), 26-32.
Kyrgios, I., Galli-Tsinopoulou A., Stylianou C., Papakonstantinou E., Arvanitidou M., & Haidich A-B. (2012).  Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.. Metabolism. 61(4), 562-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές